Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

P53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer.

PloS one - 1 Jan 2012

Chen Min-Bin, Wu Xiao-Yang, Yu Rong, Li Chen, Wang Li-Qiang, Shen Wei, Lu Pei-Hua

Abstract excerpt

BACKGROUND: Numerous studies have yielded inconsistent results regarding the relationship between p53 status and the response to neoadjuvant radiation-based therapy in patients with rectal cancer. We conducted a meta-analysis to clarify the relationship between p53 status and response to radiation-based therapy in rectal cancer. METHODS/FINDINGS: A total of 30 previously published eligible studies including 1,830...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemoradiotherapy

Share to Gamma Rays

Share to Neoadjuvant Therapy

Share to Neoplasm Grading

Share to Rectal Neoplasms

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 23049793
DOI: 10.1371/journal.pone.0045388
PMCID: PMC3458025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

P53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer.PMID 23049793Read ↗

Relationship between p53 status and response to chemotherapy in patients with gastric cancer: a meta-analysis.Semantic proximity Read ↗

Identification of neoadjuvant radiotherapy resistance genes in rectal cancer using integrated bioinformatics analysisSemantic proximity Read ↗

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.Semantic proximity Read ↗

DNA repair gene polymorphisms do not predict response to radiotherapy-based multimodality treatment of patients with rectal cancer: a meta-analysis.Semantic proximity Read ↗

Prognostic value of P53 mutations in rectal carcinoma.Semantic proximity Read ↗

p53 status: an indicator for the effect of preoperative radiotherapy of rectal cancer.Semantic proximity Read ↗

Pathological Response Has Survival Benefits for Rectal Cancer following Neoadjuvant TherapySemantic proximity Read ↗

Factors Affecting Survival Prognosis of Patients with Rectal Cancer After Neoadjuvant ChemoradiotherapySemantic proximity Read ↗

KRAS mutation is predictive for poor prognosis in rectal cancer patients with neoadjuvant chemoradiotherapy: a systemic review and meta-analysis.Semantic proximity Read ↗

Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population.Semantic proximity Read ↗

Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 study.Semantic proximity Read ↗

Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.